By giving examples for the implementation of closed, connected processing in large-scale manufacturing, this paper will help you explore and assess options that work for your objectives.
Needle innovations, including the usage of shorter needles with ultra-thin wall technology for prefilled syringes, support the delivery of drugs with greater volumes and viscosities, which greatly enhances end-user experience.
Discover an autoinjector platform that reconciles the demands of biologics with safety, reliability, and ease of use during self-injection.
To ensure business continuity during COVID-19 restrictions, we developed a virtual factory acceptance testing solution that allowed SaudiVax to advance their manufacturing plan.
This article highlights a case study on the removal of serum from the expansion step of an autologous cell therapy in a cost-effective manner without affecting cell performance.
As electronic data sources become embedded in the clinical development process, systems, processes, files, storage, and approvals are moving away from paper and becoming application dependent.
Cytiva's investment in Fortem film development will help meet industry need for a fully-characterized platform film for bioprocessing applications, with supply chain transparency as a focal point.
See how the different unit operations in a laboratory-scale monoclonal antibody (mAb) process can be connected and integrated into a semi-continuous process.
Explore a novel scale conversion tool for transferring parameters to predict the best set of cell culture parameters for single-use, stirred tank bioreactors from development to manufacturing scale.
Through an industry collaboration, Cobra and Cytiva were able to combine their expertise and experience and create a solution to meet the rising demand for high quality plasmid DNA.
Get the latest articles from Biosimilar Development delivered to your inbox.